Search results for: 'Therapy adoption'

Rare diseases pose a global burden to healthcare despite making up a very small fraction of the global disease landscape. Most treatment options for rare diseases focus on maintaining the disease symptoms, rather than a disease-modifying approach. To address this unmet need, RNA therapies are emerging as disease-modifying approaches addressing the ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming respiratory medicine, liver regeneration, metabolic disease management, infectious disease therapeutics, neurological disorders, cardiovascular risk reduction, oncology workflows, and nex...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides strategic insights into frontier innovations redefining therapeutic development, precision diagnostics, and immune modulating interventions. It showcases breakthroughs across engineered phage therapeutics, intracellular peptide platforms, advanced gene ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping therapeutics, diagnostics, and drug delivery across infectious diseases, oncology, rare genetic disorders, autoimmune conditions, cardiovascular disease, pulmonary fibrosis, neurodegeneratio...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease, nephrology, and neurodegenerative disease. It hi...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping diagnostics, therapeutics, and clinical workflows across infectious diseases, women’s health, metabolic disorders, neurodegeneration, oncology, rare diseases, and musculoskeletal care. It hi...

The artificial intelligence (AI) landscape is undergoing rapid transformation, with enterprises worldwide navigating a complex journey from experimentation to operationalization. The Global State of AI 2025 report delivers a timely, in-depth exploration of how organizations are adopting, deploying, and scaling AI technologies to drive business valu...

The rapid adoption of GLP-1 therapies is reshaping the weight management landscape and creating a new set of nutritional needs among consumers using these treatments. While GLP-1 therapies have demonstrated significant benefits for weight loss and metabolic health, associated challenges—including reduced appetite and food intake, loss of lean muscl...

The development of advanced technologies such as home sleep tests, wearables, telehealth, cloud-linked devices, and advanced sensors is shifting sleep diagnostics and treatments into home care settings. Hospitals and sleep clinics are changing their business models to focus on complex and holistic sleep care.AI implementation for automated sleep sc...